melatonin has been researched along with Cardio-Renal Syndrome in 1 studies
Cardio-Renal Syndrome: Condition where a primary dysfunction of either heart or kidney results in failure of the other organ (e.g., HEART FAILURE with worsening RENAL INSUFFICIENCY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pretreatment with melatonin attenuates renal IRI-mediated cardiac damage by maintaining myocardial diastolic function and reducing cardiomyocyte death." | 5.56 | Melatonin fine-tunes intracellular calcium signals and eliminates myocardial damage through the IP3R/MCU pathways in cardiorenal syndrome type 3. ( Li, R; Toan, S; Wang, J; Zhou, H, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, J | 1 |
| Toan, S | 1 |
| Li, R | 1 |
| Zhou, H | 1 |
1 other study available for melatonin and Cardio-Renal Syndrome
| Article | Year |
|---|---|
Melatonin fine-tunes intracellular calcium signals and eliminates myocardial damage through the IP3R/MCU pathways in cardiorenal syndrome type 3.
Topics: Animals; Antioxidants; Calcium; Calcium Channels; Cardio-Renal Syndrome; Cells, Cultured; Inositol 1 | 2020 |